Filing Details

Accession Number:
0001140361-13-010354
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-04 16:32:41
Reporting Period:
2013-02-28
Filing Date:
2013-03-04
Accepted Time:
2013-03-04 16:32:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1379006 Nanoviricides Inc. NNVC.OB Services-Commercial Physical & Biological Research (8731) 760674577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1513285 Anil Diwan 135 Wood Street
West Haven CT 06516
President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-28 250,000 $0.49 6,132,200 No 4 S Direct
Common Stock Acquisiton 2013-03-01 100,000 $0.49 6,232,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Does not include 1,000,000 shares of NanoViricides common stock issuable upon exercise of options held by Dr. Diwan that are currently exercisable or will become exercisable within 60 days or 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.